Short-term pre-operative durvalumab (MEDI 4736) in early small triple-negative breast cancer patients (POP-Durva).

Authors: Joana M. Ribeiro, Julia Dixon-Douglas, Isabelle Pic, Quentin Blampey, Elie Rassy, Nusaibah Ibrahimi, Marie-Ange Mouret-Reynier, Monica Arnedos, Olivier Tredan, Kamar Serhal, Alessandro A. Viansone, Fernando Bazan, Salim Laghouati, Barbara Pistilli, Magali Lacroix-Triki, Corinne Balleyguier, Maud Kamal, Nadege Bercovici, Paul-Henri Cournede, Fabrice Andre

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps623

Source: Full article


Abstract

TPS623